Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_assertion type Assertion NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_head.
- NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_assertion description "[The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening Programme (NZ-NCSP) and who were: (1) referred with high grade cytology with a subsequent histologically-confirmed high grade cervical intraepithelial neoplasia (CIN2/3) or adenocarcinoma in situ (AIS); or (2) were in the wider group of women who had a cytological prediction of high grade squamous disease or glandular abnormality (ASC-H/ HSIL+/AGC/AIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_provenance.
- NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_assertion evidence source_evidence_literature NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_provenance.
- NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_assertion SIO_000772 23452957 NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_provenance.
- NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_assertion wasDerivedFrom befree-20140225 NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_provenance.
- NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_assertion wasGeneratedBy ECO_0000203 NP890553.RAnQBMrIIgwy2z6ukiwSgV0BrUg5j1hJ21ZzeS4vq-3ow130_provenance.